• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » FDA approves Covidien brain aneurysm treatment | Regulatory roundup

FDA approves Covidien brain aneurysm treatment | Regulatory roundup

April 6, 2011 By MassDevice staff

Clearances roundup

The FDA granted Covidien plc (NYSE:COV) pre-market approval for its brain aneurysm treatment device.

The Mansfield, Mass.-based company designed its new endovascular device, aptly called the Pipeline, to redirect blood flow away from an aneurysm so an embolization can be performed.

It is a flexible mesh tube made of platinum and nickel-cobalt chromium alloy and indicated for treatment of "large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments," according to the company. A "giant" aneurysm can exceed 1.25 inches in size, according to the FDA.

Large or giant, wide-neck aneurysms "remained an unmet clinical need until now," Brain Aneurysm Foundation executive director Christine Buckley said in prepared remarks.

The Pipeline gives "neurointerventional surgeons an alternative to open surgery or placement of materials such as coils or a liquid embolic," Center for Devices and Radiological Health Office of Device Evaluation acting director Christy Foreman said in prepared remarks.

The Pipeline device won CE Mark (Conformité Européenne) approval in Europe and has been sold outside the United States since July 2009 when it was still made by ev3 Inc., which Covidien acquired last July. Covidien plans to begin selling the device in the U.S. this quarter, the company said.

The Pipeline’s approval had been expected after an FDA advisory panel in March recommended that the agency approve the device. The FDA had also granted ev3 Inc. expedited review for its PMA application for the device, a month before Covidien closed its buyout of the company.

"Although likely not material to COV’s financials near-term — due to a relatively modest initial market opportunity [$100-150 million and about 2,000 patients per year] and an expected controlled launch by COV— COV now has yet another highly differentiated product to sell in its growing portfolio of innovative solutions," Leerink Swan analyst Rick Wise wrote in a note to investors.

COV shares rose 31 cents, or .6 percent, to close at $52.72.

Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

  • Philips wins 510(k) clearance for Ingenia MRI system
    Royal Philips Electronics (NYSE:PHG) announced the U.S. availability of the Ingenia MRI system, the first-ever digital broadband magnetic resonance imaging solution. Previously available in Europe, Canada and Japan, the system has received 510(k) clearance from the FDA. Ingenia MRI delivers exceptional image clarity, scanning efficiency and scalability designed to advance diagnosis and radiology workflow.
    Read more
  • FDA clears Mandometer eating disorders treatment
    The FDA announced on March 31 that it had cleared Mandometer for the treatment of patients with eating disorders. Mandometer is a device that provides biofeedback allowing individuals to monitor their rate of eating and their development of satiety during meals and in comparison to those eating normally.
    Read more
  • Alphatec Spine wins clearance for Solus fusion system
    Alphatec Holdings Inc. (NSDQ:ATEC), the parent company of Alphatec Spine Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders announced it received 510(k) clearance from the FDA for its Solus Anterior Lumbar Interbody Fusion (ALIF) system.
    Read more
  • Alere earns NCQA certification for health information line
    Alere Health LLC announced that it has achieved the National Committee for Quality Assurance (NCQA) Health Information Products Certification for Health Information Line. The accreditation is for Alere’s Nurse24(SM) program − a 24/7 nurseline staffed by highly experienced, registered nurses that empowers individuals to make smarter healthcare decisions by providing immediate clinical support for everyday health issues and questions that otherwise might lead to unnecessary doctor or emergency room visits.
    Read more
  • Spectranetics announces approval of LLD in Japan
    Spectranetics Corp. (NSDQ:SPNC) announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads. The LLD secures leads along the entire length of their hollow inner lumen, permitting physicians to apply steady traction on the lead during the removal process.
    Read more
  • IRIS International wins FDA clearance for urinalysis workstation
    IRIS International Inc. (NSDQ:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, announced today that, following recent 510(k) market clearance on March 24 from the FDA.
    Read more
  • NeuroVasx wins FDA approval for cPAX aneurysm treatment system
    NeuroVasx announced that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device (HDE) for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat. The HDE allows for the treatment of up to 4,000 patients per year in the U.S.
    Read more
  • Titan Spine wins CE Mark for Endoskeleton fusion devices
    Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, received CE Mark approval to commercially release its line of Endoskeleton lumbar interbody fusion devices in Europe. The implants, which consist of the Endoskeleton TA (ALIF), Endoskeleton TT (TLIF), and Endoskeleton TO (PLIF and Oblique), feature a unique roughened titanium surface topography that is designed to promote rapid bony integration and subsequent fusion.
    Read more
  • Reverse Medical wins CE Mark intracranial distal access catheter
    Reverse Medical Corp. received CE Mark approval for its ReFlex™ A+ Catheter for intracranial distal access, delivery and aspiration. The ReFlex A+ Catheter is uniquely designed to provide endovascular intracranial access during interventional neurovascular procedures.
    Read more
  • Hospira submits 510(k) application for Symbiq modifications
    Hospira Inc. (NYSE:HSP), a provider of clinical information and medication delivery technologies, today announced that the company submitted a 510(k) application with the FDA for modifications to the Symbiq infusion system. The submission is one of the first developed to align with the recent FDA draft guidance for 510(k) infusion pump clearances.
    Read more
  • CryoLife files IDE to begin trials for PerClot
    CryoLife Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced that it has filed an "Investigational Device Exemption" with the FDA to begin clinical trials for the purpose of obtaining a PMA to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
    Read more

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Alere, Alphatec, Covidien, CryoLife, Hospira Inc., IRIS International Inc., Philips, Reverse Medical Corp., Spectranetics Corp.

In case you missed it

  • House committee investigates $70M federal contract for AutoMedx ventilators
  • Edwards Lifesciences misses on earnings in Q4
  • COVID-19 assays sales power Hologic to Street-beating Q1
  • Stryker beats the Street on earnings but misses on revenue in Q4
  • How CGMs can inspire lifestyle changes
  • Johnson & Johnson gearing up for COVID-19 vaccine data announcement
  • Sanofi to provide COVID-19 vaccine manufacturing for rival Pfizer
  • Adapting to Pharma’s Next Normal – 2021 Pharmaceutical Trends
  • COVID-19 test sales boost Abbott in Street-beating Q4
  • Varian posts mixed bag Q1 results, expects Siemens Healthineers takeover to complete in early 2021
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
  • Titan Medical closes on $11.5M offering
  • GE ticks up on mixed-bag Q4
  • BD CEO Polen to also serve as board chair
  • Moderna details ‘proactive’ strategy to fight emerging COVID-19 variants  
  • Surmodics’ DCB shown non-inferior to Medtronic’s In.Pact Admiral
  • Longeviti Neuro Solutions ClearFit implant wins FDA clearance for use in ultrasound

RSS From Medical Design & Outsourcing

  • House committee investigates $70M federal contract for AutoMedx ventilators
    A Congressional committee has launched an investigation into a $70 million White House contract for ventilators that reportedly are inadequate to treat people with COVID-19. The Department of Defense signed a $16.2 million contract in spring 2020 to buy SAVe II ventilators, manufactured by AutoMedx (Addison, Tex.), from the supplier Combat Medical Systems, according to… […]
  • How CGMs can inspire lifestyle changes
    As an early adopter of fitness trackers such as the Fitbit, I’ve long appreciated the power of health data. But my recent experience with a continuous glucose monitor (CGM) has done far more to inspire me to look after my health — even as a nondiabetic. I had heard about the potential of such technology… […]
  • COVID-19 mask factory opens in N.J.
    Hudson Holdings Group today announced it has opened a factory to make up to tens of millions of protective masks a month. The Piscataway, N.J., site will produce more than 200 jobs, according to the company, which is in partnership on the project with the State of New Jersey. “Our ultimate goal is to help,”… […]
  • TE Connectivity posts Street-beating Q1 results, medical sales dip 12%
    TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus on Wall Street. The Schaffhausen, Switzerland-based company reported profits of $381 million, or $1.13 per share, on sales of $3.5 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 1365.4% sales growth of 11.2% compared with Q1 2020. Adjusted to… […]
  • Could this 3-D printed ‘biomesh’ minimize hernia repair complications?
    Some hernia mesh implants have been associated with adverse post-surgical complications. So researchers at Baylor College of Medicine have developed a 3D-printed biomesh to support and reinforce the damaged abdominal wall and facilitate the healing process. Mesh implants may fail because they promote the adhesion of the intestine, liver or other visceral organs to the… […]
  • Superior Sensor Technology launches versatile differential pressure sensors
    Superior Sensor Technology (Santa Clara, Calif.) today announced the launch of differential pressure sensors for industrial applications that support up to seven selectable pressure ranges in one device. Designed for a wide range of applications, the new ND Series sensors support pressure ranges as low as 62.5 Pa/0.25” H2O to as high as 345 mBar/5… […]
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
    Becton Dickinson (BD) is touting the results of a small, in-house study of its Veritor Plus antigen test over molecular (PCR) tests to indicate whether an infected person is more likely able to spread SARS-CoV-2. The peer-reviewed study compared antigen and PCR test results to positive results using a viral cell culture test. Viral growth… […]
  • TDK adds pressure sensors for ventilators
    TDK Corporation announced the launch of a new range of differential pressure sensors designed as printed circuit boards for use in medical devices. The sensors are designed for measurement ranges of 16 mbar full-scale (FS), 100 mbar FS and 7 bar FS, with accuracy of up to ±1% FS at temperatures from -20 °C to… […]
  • Pediatric device workshop scheduled for February
    A virtual public meeting on pediatric medical device development is scheduled for Feb. 9-11, 2021. Sponsors include the FDA, AdvaMed, the American Academy of Pediatrics and the Critical Path Institute, a public-private partnership that receives FDA funding. The System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop will focus on the… […]
  • Pedra wins breakthrough nod for perfusion system
    Singapore-based Pedra Technology announced today that the FDA has granted the company breakthrough device designation for the periprocedural use of its Xauron perfusion system in the treatment of critical limb-threatening ischemia (CLTI). CLTI is a severe form of peripheral artery disease (PAD) that is defined as ischemic rest pain, tissue loss or gangrene (tissue death) that… […]
  • Freudenberg Medical expands U.S. molding operations
    Freudenberg Medical announced that it has expanded injection molding operations at its Baldwin Park, Calif., operation, which is focused on thermoplastics. Freudenberg Medical Baldwin Park has added six injection molding machines including three new Arburg molding machines, a work cell for two-shot molding and a Wittmann Battenfeld micro-molding machine with in-process visual inspection capability. The… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS